Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology for the
treatment of coronary artery disease. The technology was introduced to overcome limitations …

Introduction: Bioresorbable scaffold technology provides transient vessel support with drug-
delivery capability without the long-term limitations of the permanent metallic drug-eluting …

Aims Patients with ST-segment elevation myocardial infarction (STEMI) feature thrombus-
rich lesions with large necrotic core, which are usually associated with delayed arterial …

Background Serine proteinase inhibitor A3 (Serpina3), initially discovered as an acute
phase plasma protease inhibitor, has been demonstrated in the pathology of complex …

Today, drug-eluting metal stents are considered the gold standard for interventional
treatment of coronary artery disease. While providing inhibition of neointimal hyperplasia …

Bioresorbable scaffolds provide transient vessel support without the long-term limitations of
permanent metallic drug-eluting stents. The sirolimus-eluting resorbable magnesium …

(1) Background: The diagnostic accuracy of coronary computed tomography angiography
(CCTA) for coronary artery disease (CAD) has greatly improved so CCTA represents a …

Purpose: The objectives of this review were to:(1) identify the acute cardiovascular
responses to aerobic exercise used in an exercise stress test (EST),(2) identify when and …

Objective: Both Aspirin and Clopidogrel are considered as effective drugs in decreasing
ischemic events, which potentially contribute to a promising application regarding the …

Background/aims Drug eluting stent (DES) decrease the risk of restenosis by reducing the
neointimal response. However, DES may impair strut coverage, and this has been …